Rock Springs Capital Management LP Q3 2023 Filing

Filed November 14, 2023

Portfolio Value

$3.7B

Holdings

120

Report Date

Q3 2023

Filing Type

13F-HR

All Holdings (120 positions)

#	Stock	Shares	Value	% Portfolio
101	BMEABIOMEA FUSION INC	181,147	$2.0M	0.05%
102	GOSSGOSSAMER BIO INC	3,266,960	$2.0M	0.05%
103	DSGNDESIGN THERAPEUTICS INC	460,391	$1.0M	0.03%
104	NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC	1,000,000	$1.0M	0.03%
105	FATEFATE THERAPEUTICS INC	612,215	$1.0M	0.03%
106	SYREAEGLEA BIOTHERAPEUTICS INC	136,556	$1.0M	0.03%
107	CYPHLEAP THERAPEUTICS INC	1,074,517	$1.0M	0.03%
108	CGENCOMPUGEN LTD	1,289,990	$1.0M	0.03%
109	SLRNACELYRIN INC	141,876	$1.0M	0.03%
110	—THESEUS PHARMACEUTICALS INC	437,329	$1.0M	0.03%
111	—VINCERX PHARMA INC	891,719	$901K	0.02%
112	—KINNATE BIOPHARMA INC	405,811	$568K	0.02%
113	NVRO 2.75 04/01/25NEVRO CORP	500,000	$472K	0.01%
114	NKTXNKARTA INC	331,571	$461K	0.01%
115	DP8CERVOMED INC	80,033	$370K	0.01%
116	NVTA1EURINVITAE CORP	585,659	$354K	0.01%
117	TLPHACELRX PHARMACEUTICALS INC	316,460	$184K	0.00%
118	UNHUNITEDHEALTH GROUP INC	230,000	$115K	0.00%
119	SPROSPERO THERAPEUTICS INC	57,373	$69K	0.00%
120	—GAMIDA CELL LTD	52,015	$54K	0.00%

PreviousPage 2 of 2